Chemical Structure : (±)-Zanubrutinib
CAS No.: 1633350-06-7
Catalog No.: PC-42396Not For Human Use, Lab Use Only.
The active enantiomer of Zanubrutinib, a potent, selective and orally available Btk inhibitor.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $280 | In stock | |
10 mg | $400 | In stock | |
50 mg | $1200 | In stock | |
100 mg | $1680 | In stock |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
The active enantiomer of Zanubrutinib (BGB3111), a potent, selective and orally available Btk inhibitor; shows much more restricted off-target activities against a panel of kinases, including ITK, compared with Ibrutinib; demonstrates nanomolar BTK inhibition activity, inhibits BCR aggregation-triggered BTK autophosphorylation, blocks downstream PLC-γ2 signaling, and potently inhibits cell proliferation in several MCL and DLBCL cell lines; demonstrates better anti-tumor activity than ibrutinib in TMD-8 subcutaneous xenograft model.
Blood Cancer
Phase 3 Clinical
M.Wt | 471.55086 | |
Formula | C27H29N5O3 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
Pyrazolo[1,5-a]pyrimidine-3-carboxamide, 4,5,6,7-tetrahydro-7-[1-(1-oxo-2-propen-1-yl)-4-piperidinyl]-2-(4-phenoxyphenyl)- |
1. Na Li, et al. Abstract 2597: BGB-3111 is a novel and highly selective Bruton's tyrosine kinase (BTK) inhibitor. AACR.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright